GenVec

From Wikipedia, the free encyclopedia
  (Redirected from TNFerade)
Jump to: navigation, search
GenVec, Inc.
Public company
Traded as NASDAQGNVC
Industry Pharmaceuticals
Headquarters Gaithersburg, Maryland, United States
Key people

Douglas J. Swirsky, President and CEO

num_employees = 11
Products CGF166Clinical trial#Phase 1/2
Decrease
Website www.genvec.com

GenVec, Inc. (NASDAQ: GNVC) is a pioneering biopharmaceutical company working to build a pipeline of therapeutics and vaccines based on its adenovector technology platform that can realize the promise of gene-based medicine. The company's lead product candidate for hearing loss and balance disorders, partnered with Novartis, is in a first-in-man gene delivery Phase 1/2 clinical trial in patients with severe to profound hearing loss. GenVec therapeutics and vaccines have been administered to over 3,000 clinical study subjects.

References[edit]